Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

821
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
821
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.2K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

613
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
613
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.7K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

95
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
95
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

595
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
595

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of Novel LRPPRC Inhibitors Featuring a Biphenyl-Acylhydrazone Scaffold with Potent Broad-Spectrum Antitumor Activity.

Journal of medicinal chemistry·2026
Same author

MRDsteer: quality-aware AI-driven closed-loop optimization enhances ctDNA-based minimal residual disease detection.

Briefings in bioinformatics·2026
Same author

A novel dual-lock-dual-key naphthalimide-based fluorescent probe for the detection of H<sub>2</sub>S and H<sub>2</sub>O<sub>2</sub>.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

Cardiac sympathetic afferent denervation improves cardiac post-ischemic remodeling by maintaining autonomic tone.

International journal of cardiology. Heart & vasculature·2026
Same author

A comparative study of machine learning models for microbiome-based diagnosis and multi-class staging of colorectal cancer.

Scientific reports·2026
Same author

Calcium overload induces reactive oxygen species to enhance glioblastoma radiosensitivity.

Medical gas research·2026

Related Experiment Video

Updated: Apr 16, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

9.0K

Epigenetics in atherosclerosis: a clinical perspective.

Bi-Kui Zhang1, Xin Lai2, Su-Jie Jia3

  • 1Department of Pharmacy, The Second Xiangya Hospital; and Institute of Clinical Pharmacy; Central South University, Changsha, Hunan, 410011, China.

Discovery Medicine
|March 1, 2015
PubMed
Summary

Epigenetic mechanisms like DNA methylation and microRNA are key to atherosclerosis development. Targeting these reversible processes offers promising new treatments for this widespread cardiovascular disease.

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.9K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

41.2K

Related Experiment Videos

Last Updated: Apr 16, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

9.0K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.9K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

41.2K

Area of Science:

  • Cardiovascular Science
  • Molecular Biology
  • Genetics

Background:

  • Atherosclerosis is a major global health threat despite significant research.
  • Understanding its pathogenesis is crucial for developing effective treatments.

Purpose of the Study:

  • To review current epigenetic mechanisms in atherosclerosis pathogenesis.
  • To identify potential therapeutic targets within these epigenetic processes.

Main Methods:

  • Review of in vitro and in vivo studies.
  • Analysis of drugs targeting epigenetic modification enzymes.
  • Synthesis of current literature on epigenetic regulation in atherosclerosis.

Main Results:

  • Epigenetic mechanisms (DNA methylation, histone modification, microRNA) are integral to atherosclerosis.
  • Epigenetic processes are reversible, unlike genetic mutations.
  • Drug-based interventions targeting epigenetic enzymes show therapeutic promise.

Conclusions:

  • Epigenetics provides critical insights into atherosclerosis pathogenesis.
  • Reversible epigenetic modifications represent viable therapeutic targets.
  • Further research into targeting epigenetic pathways could lead to novel atherosclerosis treatments.